IMPACT OF RISANKIZUMAB ON INTESTINAL STENOSIS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: POST HOC ANALYSIS OF THE PHASE 3 ADVANCE, MOTIVATE, AND FORTIFY STUDIES
Walter Reinisch 1
Florian Rieder 2
Vipul Jairath 3, 4
Makoto Sasaki 5
Kristina Kligys 6
Ezequiel Neimark 6
Javier Zambrano 6
Yafei Zhang 6
Jean-Frédéric Colombel 7
1 Medical University of Vienna, Vienna, Austria
2 Cleveland Clinic, Cleveland, United States
3 University Hospital, London, Canada
4 Western University, London, Canada
5 Aichi Medical University School of Medicine, Nagakute, Japan
6 AbbVie Inc., North Chicago, United States
7 Icahn School of Medicine at Mount Sinai, New York, United States
Topic
Endoscopy, IBD
Session
Hit the road JAK: Part 1
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]